Jenburkt Pharmaceuticals Ltd Q1FY23 net profit climbs to Rs. 5.95 crores

JENBURKT PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 32.2745 crores during the period ended June 30, 2022 as compared to Rs. 29.5683 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 5.9532 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 3.4488 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 12.97 for the period ended June 30, 2022 as compared to Rs. 7.51 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 32.2745 crs	₹29.5683 crs	9.15%
Net Profit	₹5.9532 crs	₹3.4488 crs	72.62%
EPS	₹12.97	₹7.51	72.70%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 32.2745 crores during the period ended June 30, 2022 as compared to Rs.28.3747 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.5.9532 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.4.6509 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.12.97 for the period ended June 30, 2022 as compared to Rs.10.13 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 32.2745 crs	₹28.3747 crs	13.74%
Net Profit	₹5.9532 crs	₹4.6509 crs	28.00%
EPS	₹12.97	₹10.13	28.04%

Shares of JENBURKT PHARMACEUTICALS LTD. was last trading in BSE at Rs. 526.60 as compared to the previous close of Rs. 528.10. The total number of shares traded during the day was 911 in over 94 trades.

The stock hit an intraday high of Rs. 539.05 and intraday low of 525.00. The net turnover during the day was Rs. 485188.00.

Source : Equity Bulls

Keywords

JenburktPharmaceuticals Q1FY23 ResultUpdate